Literature DB >> 26089097

Dynamical properties of a minimally parameterized mathematical model for metronomic chemotherapy.

Heinz Schättler1, Urszula Ledzewicz2, Behrooz Amini3.   

Abstract

A minimally parameterized mathematical model for low-dose metronomic chemotherapy is formulated that takes into account angiogenic signaling between the tumor and its vasculature and tumor inhibiting effects of tumor-immune system interactions. The dynamical equations combine a model for tumor development under angiogenic signaling formulated by Hahnfeldt et al. with a model for tumor-immune system interactions by Stepanova. The dynamical properties of the model are analyzed. Depending on the parameter values, the system encompasses a variety of medically realistic scenarios that range from cases when (i) low-dose metronomic chemotherapy is able to eradicate the tumor (all trajectories converge to a tumor-free equilibrium point) to situations when (ii) tumor dormancy is induced (a unique, globally asymptotically stable benign equilibrium point exists) to (iii) multi-stable situations that have both persistent benign and malignant behaviors separated by the stable manifold of an unstable equilibrium point and finally to (iv) situations when tumor growth cannot be overcome by low-dose metronomic chemotherapy. The model forms a basis for a more general study of chemotherapy when the main components of a tumor's microenvironment are taken into account.

Entities:  

Keywords:  Dynamical system; Metronomic chemotherapy; Modeling of cancer treatment; Saddle-node bifurcations; Tumor microenvironment

Mesh:

Substances:

Year:  2015        PMID: 26089097     DOI: 10.1007/s00285-015-0907-y

Source DB:  PubMed          Journal:  J Math Biol        ISSN: 0303-6812            Impact factor:   2.259


  32 in total

1.  Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice.

Authors:  D Hanahan; G Bergers; E Bergsland
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  On optimal chemotherapy with a strongly targeted agent for a model of tumor-immune system interactions with generalized logistic growth.

Authors:  Urszula Ledzewicz; Omeiza Olumoye; Heinz Schättler
Journal:  Math Biosci Eng       Date:  2013-06       Impact factor: 2.080

Review 3.  The angiopoietins: Yin and Yang in angiogenesis.

Authors:  S Davis; G D Yancopoulos
Journal:  Curr Top Microbiol Immunol       Date:  1999       Impact factor: 4.291

4.  Tumor cells proliferation and migration under the influence of their microenvironment.

Authors:  Avner Friedman; Yangjin Kim
Journal:  Math Biosci Eng       Date:  2011-04       Impact factor: 2.080

5.  On mathematical modeling of critical variables in cancer treatment (goals: better understanding of the past and better planning in the future).

Authors:  H E Skipper
Journal:  Bull Math Biol       Date:  1986       Impact factor: 1.758

6.  Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers.

Authors:  Sébastien Benzekry; Philip Hahnfeldt
Journal:  J Theor Biol       Date:  2013-07-11       Impact factor: 2.691

7.  A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer.

Authors:  Kristian Pietras; Douglas Hanahan
Journal:  J Clin Oncol       Date:  2004-11-22       Impact factor: 44.544

Review 8.  Immune surveillance of tumors.

Authors:  Jeremy B Swann; Mark J Smyth
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

9.  Interaction of tumor with its micro-environment: A mathematical model.

Authors:  Yangjin Kim; Avner Friedman
Journal:  Bull Math Biol       Date:  2009-11-12       Impact factor: 1.758

Review 10.  The tumor microenvironment and its role in promoting tumor growth.

Authors:  T L Whiteside
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

View more
  5 in total

1.  Role of vascular normalization in benefit from metronomic chemotherapy.

Authors:  Fotios Mpekris; James W Baish; Triantafyllos Stylianopoulos; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-07       Impact factor: 11.205

2.  Modeling and Analysis of Breast Cancer with Adverse Reactions of Chemotherapy Treatment through Fractional Derivative.

Authors:  Tao-Qian Tang; Zahir Shah; Ebenezer Bonyah; Rashid Jan; Meshal Shutaywi; Nasser Alreshidi
Journal:  Comput Math Methods Med       Date:  2022-02-12       Impact factor: 2.238

3.  Modeling treatment-dependent glioma growth including a dormant tumor cell subpopulation.

Authors:  Marvin A Böttcher; Janka Held-Feindt; Michael Synowitz; Ralph Lucius; Arne Traulsen; Kirsten Hattermann
Journal:  BMC Cancer       Date:  2018-04-03       Impact factor: 4.430

4.  Delicate Balances in Cancer Chemotherapy: Modeling Immune Recruitment and Emergence of Systemic Drug Resistance.

Authors:  Anh Phong Tran; M Ali Al-Radhawi; Irina Kareva; Junjie Wu; David J Waxman; Eduardo D Sontag
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

5.  Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy.

Authors:  Fotios Mpekris; Chrysovalantis Voutouri; Myrofora Panagi; James W Baish; Rakesh K Jain; Triantafyllos Stylianopoulos
Journal:  J Control Release       Date:  2022-03-08       Impact factor: 11.467

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.